Iopydol
Chemical compound
- V08AD02 (WHO)
- 1-(2,3-dihydroxypropyl)-3,5-diiodo-1,4-dihydropyridin-4-one
- 5579-92-0 Y
- 21751
- DB13389 Y
- 20443 N
- T4661K682A
- D04586 Y
- DTXSID90863565
- Interactive image
- C1=C(C(=O)C(=CN1CC(CO)O)I)I
InChI
- InChI=1S/C8H9I2NO3/c9-6-2-11(1-5(13)4-12)3-7(10)8(6)14/h2-3,5,12-13H,1,4H2 N
- Key:TZADDXVKYWMEHX-UHFFFAOYSA-N N
Iopydol is a pharmaceutical drug used as a radiocontrast agent in X-ray imaging.[1][2]
See also
- Iodinated contrast
References
- ^ DrugBank DB13389
- ^ Bétrémieux P, Tréguier C, Pladys P, Bourdinière J, Leclech G, Lefrancois C (January 1995). "Tracheobronchography and balloon dilatation in acquired neonatal tracheal stenosis". Archives of Disease in Childhood. Fetal and Neonatal Edition. 72 (1): F3-7. doi:10.1136/fn.72.1.f3. PMC 2528410. PMID 7743281.
- v
- t
- e
Contrast media (V08)
Iodinated, Water soluble |
| ||||||
---|---|---|---|---|---|---|---|
Iodinated, Water insoluble |
| ||||||
Non-iodinated |
Paramagnetic | |
---|---|
Superparamagnetic |
|
Other |
- Microspheres of human albumin
- Microparticles of galactose
- Perflenapent
- Microspheres of phospholipids
- Sulfur hexafluoride
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e